/Cencora%20Inc_%20chart%20on%20phone-by%20T_Schneider%20via%20Shutterstock.jpg)
With a market cap of $46.8 billion, Cencora, Inc. (COR) focuses on pharmaceutical distribution and healthcare services. The Conshohocken, Pennsylvania-based company provides extensive solutions including distribution, consulting, and logistics to support healthcare providers, biotechnology, and pharmaceutical manufacturers globally. COR is expected to unveil its fiscal Q4 earnings results before the market opens on Wednesday, Nov. 6.
Before the event, analysts anticipated the prescription drug distributor to report a profit of $3.21 per share, up 12.2% from $2.86 per share in the same quarter last year. The company has consistently surpassed Wall Street's earnings projections in the past four quarters. COR exceeded the consensus estimate by a margin of 5% in the last reported quarter.
